Physiomics (LON:PYC – Get Free Report) released its quarterly earnings results on Tuesday. The company reported GBX (0.20) EPS for the quarter, Digital Look Earnings reports. Physiomics had a negative net margin of 74.06% and a negative return on equity of 152.03%.
Physiomics Trading Down 5.3%
Shares of PYC traded down GBX 0.03 during mid-day trading on Friday, reaching GBX 0.45. The company’s stock had a trading volume of 2,002,172 shares, compared to its average volume of 5,670,800. The business has a 50-day simple moving average of GBX 0.49 and a two-hundred day simple moving average of GBX 0.51. The stock has a market cap of £2.04 million, a P/E ratio of -3.00 and a beta of 1.05. Physiomics has a 1-year low of GBX 0.25 and a 1-year high of GBX 0.80.
Physiomics Company Profile
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
See Also
- Five stocks we like better than Physiomics
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
